Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
Launched by ARIZONA STATE UNIVERSITY · Mar 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Smart Walk clinical trial is studying a special program designed to help African American women increase their physical activity using a smartphone app. The goal is to reduce the risk of heart disease and type 2 diabetes by encouraging regular exercise. The study is currently looking for women aged 24 to 65 who are not very active (doing less than 60 minutes of moderate exercise each week) and have a body mass index (BMI) over 30, which indicates they may be overweight. Participants should be able to read and speak English, own a smartphone capable of downloading apps and receiving texts, and be open to using the app to help them get more active.
If you decide to join the study, you will receive support and resources through the app to help you increase your physical activity. It's important to note that there are certain criteria that would exclude someone from participating, such as having serious health issues or being pregnant. This program aims to create a supportive environment tailored to the needs of African American women, helping them lead healthier, more active lives.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-reported African American/Black female
- • Aged of 24-65 years
- • Insufficiently Active (\< 60 minutes of moderate-to-vigorous physical activity per week as measured by Exercise Vital Sign Questionnaire)
- • BMI \> 30 kg/m2
- • English speaking and reading
- • Ownership of a smartphone with the ability to download applications (i.e., apps)
- • Ownership of a smartphone with the ability to receive text messages
- • Willingness to receive a physical activity intervention delivered through their smartphone
- • Willingness to include their first name or create an alias to be used on their profile page on the Smart Walk app
- Exclusion Criteria:
- • Plans to relocate out of Phoenix area in next 12 months
- • Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a doctor's note for study participation in provided
- • Resting systolic blood pressure greater than 180 mmHG and/or a diastolic blood pressure greater than 120 mmHG , as assessed at baseline or at any other study assessment
- • Self-reported participation in another diet or weight loss study at screening
- • Pregnant or planning to become pregnant in the next 12 months
About Arizona State University
Arizona State University (ASU) is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, ASU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical research practices and collaboration with healthcare professionals, ASU strives to translate research findings into practical applications that benefit society. The university's focus on community engagement and real-world impact underscores its role as a pivotal player in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phoenix, Arizona, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported